COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn PVP-IPVP-I FLVFLV REGNR2 LY-CoVLY RemdesivirRMD
Ivermectin study #29 of 63
11/13 Prophylaxis study
Elgazzar et al., Research Square, doi:10.21203/rs.3.rs-100956/v2 (Preprint)
Efficacy and Safety of Ivermectin for Treatment and prophylaxis of COVID-19 Pandemic
Source   PDF   Share   Tweet
RCT for prophylaxis with ivermectin showing a significant reduction in cases with treatment.
Relative risk of COVID-19 case RR 0.2, p = 0.03
This paper also reports a treatment study [1].

Elgazzar et al., 11/13/2020, Randomized Controlled Trial, Egypt, Africa, preprint, 6 authors, dosage 400μg/kg weekly.
risk of COVID-19 case, 80.0% lower, RR 0.20, p = 0.03, treatment 2 of 100 (2.0%), control 10 of 100 (10.0%).

Effect extraction follows pre-specified rules prioritizing more serious outcomes. For an individual study the most serious outcome may have a smaller number of events and lower statistical signficance, however this provides the strongest evidence for the most serious outcomes when combining the results of many trials.
Details of all 63 studies    Meta analysis
Please send us corrections, updates, or comments.
Submit